By Lucy Rana and Huda Jafri
Introduction
In intellectual property strategy, the most consequential decisions are often not what a company chooses to patent, but what it deliberately chooses not to patent.
Modern innovation ecosystems generate far more technical output than any organisation can economically prosecute through the patent system. Engineering teams iterate continuously. Manufacturing operations accumulate incremental process improvements. Software systems evolve through constant optimisation. Taken individually, these developments may appear incremental; collectively, they often represent a material source of competitive advantage.
Yet many organisations continue to treat IP decision-making as a binary exercise: file a patent, or set the invention aside.
That approach is increasingly inadequate in a patent environment characterised by rising prosecution costs, dense prior-art landscapes, and aggressive filing strategies by competitors seeking protection over adjacent technical space. Between secrecy and exclusivity lies a third, underutilised instrument used in practice by technology-driven organisations: defensive publication.
At its core, the logic is straightforward. A timely, public, and sufficiently enabling disclosure of technical subject matter can become prior art and may therefore defeat the novelty of later patent applications directed to the same invention. The disclosing party does not obtain exclusivity. Instead, it reduces the risk that exclusivity will later be asserted by others over the disclosed subject matter.
The Decision Most IP Committees Get Wrong
There is a familiar pattern in well-run R&D organisations. The chief technology officer, in-house counsel, and finance representatives meet to review a quarterly invention disclosure list. The default classification is simple: patent or park.
The patent category receives budget allocation, drafting support, and filing timelines. The “park” category is typically treated as non-strategic and is set aside without further structured analysis or documentation.
That treatment is frequently incomplete.
Between these two categories lies a third and often strategically relevant option: inventions that are neither patented nor abandoned, but deliberately and systematically published. Properly implemented, defensive publication is not a residual disposal mechanism for low-value ideas. It is a proactive intellectual property tool that can reduce future exclusion risk and optimise patent spend.
For Indian enterprises and multinational corporations with significant R&D activity in India, the absence of a structured defensive publication practice can create latent exposure. This exposure often surfaces years later in the form of infringement assertions, licensing demands, or adverse positions during due diligence.
A patent confers an exclusionary right. A defensive publication does not create exclusivity, but it may reduce the likelihood that others can later obtain enforceable exclusivity over the disclosed subject matter.
Nature and Legal Effect of Defensive Publication
A defensive publication is the deliberate, time-stamped, and publicly accessible disclosure of technical information relating to an invention in sufficient detail to constitute prior art under applicable patent law.
Once established as prior art, such disclosure may be used to challenge novelty, and in appropriate cases inventive step, of later patent applications directed to the same subject matter.
The disclosing party does not acquire proprietary rights through publication. Instead, it gains a form of legal positioning: the subject matter is placed into the public domain in a manner that may prevent subsequent valid patent monopolisation, subject to claim scope and potential improvements by third parties.
Accordingly, defensive publication is best understood as the strategic counterpart to patenting. A patent creates exclusivity for a limited term. A defensive publication ensures that exclusivity does not later arise over the disclosed technical teaching.
Importantly, this should be understood as a risk-reduction mechanism, not a guarantee of freedom to operate against all present or future third-party rights.
The Indian Statutory Framework
Indian patent law does not expressly define or codify “defensive publication”. The concept is derived from the statutory scheme governing novelty, anticipation, examination, opposition, and revocation under the Patents Act, 1970.
Section 2(1)(j) defines an invention as a new product or process involving an inventive step and capable of industrial application.[1] Section 13 provides for search and examination relating to anticipation by prior publication and prior claim.[2] Sections 25(1)(b) and 25(2)(b) provide grounds for pre-grant and post-grant opposition where an invention has been previously published before the priority date.[3] Section 64(1)(e) permits revocation where the invention is not new having regard to prior publication or public knowledge.[4]
Section 29 addresses limited circumstances in which certain disclosures will not be treated as anticipation.[5] However, the overall statutory scheme remains clear: a public disclosure that is enabling and accessible may form prior art capable of defeating patentability.
This principle is reflected in judicial precedent. In Bishwanath Prasad Radhey Shyam v. Hindustan Metal Industries Ltd., the Hon’ble Supreme Court reaffirmed that novelty is a fundamental requirement of patentability, and that prior publication or public knowledge can negate it.[6]
In Monsanto Co. v. Coromandel Indag Products (P) Ltd., the Court accepted that prior technical disclosure in published literature could constitute anticipation sufficient to invalidate later patent claims.[7]
Taken together, these authorities confirm that prior public disclosure, where sufficiently clear and relevant, can form the basis for successful opposition or revocation under Indian patent law.
When Publication May Be Preferable to Patenting
The decision to patent or publish is fundamentally commercial. Several recurring categories illustrate where defensive publication may be strategically appropriate.
-
Incremental Technical Improvements
R&D pipelines routinely generate incremental improvements in process parameters, software performance, tooling, and manufacturing efficiency.
Individually, these may not justify the cost of patent prosecution. Collectively, however, they may represent significant operational value.
Attempting to patent all such developments is economically inefficient. However, leaving them unaddressed may create a risk that third parties later obtain patents covering similar subject matter. Defensive publication can reduce this risk at comparatively low cost.
-
Process and Manufacturing Know-How
Certain process innovations are not readily reverse-engineered and may initially appear suitable for trade secret protection. However, trade secret protection depends on sustained confidentiality, which may be undermined by employee mobility, vendor ecosystems, and industry diffusion.
Where long-term confidentiality cannot be reliably ensured, defensive publication may serve as a structured alternative to reduce the risk of later exclusion by third-party patents.
-
Platform and Ecosystem Technologies
In technology ecosystems dependent on interoperability, value is often driven by adoption rather than exclusivity. Interface standards, protocol definitions, and architectural conventions may derive greater utility when widely implemented.
In such cases, defensive publication can support ecosystem growth while reducing the risk of fragmentation through third-party patenting of foundational elements.
-
Portfolio Rationalisation
Mature patent portfolios often include peripheral inventions that do not materially contribute to competitive advantage.
Maintaining such filings may dilute resources better allocated to core innovations. Conversely, abandoning them without publication may create avoidable freedom-to-operate risk. Defensive publication provides an intermediate option that preserves legal positioning while optimising patent spend.
Practical Drivers
Three common commercial drivers typically inform the use of defensive publication.
For early-stage companies, the primary constraint is capital efficiency. Defensive publication allows selective preservation of freedom to operate while concentrating patent spend on core inventions.
For large enterprises, the primary concern is defensive positioning against future patent assertions. Properly documented prior art can be critical in invalidity proceedings or settlement negotiations.
For academic and research institutions, defensive publication supports dissemination of research outputs while reducing the risk of unintended privatisation of broadly known technical contributions.
Requirements for Prior Art Effectiveness
For a defensive publication to function effectively as prior art, three conditions are generally required.
-
Enabling Disclosure
The disclosure should be sufficiently detailed to enable a person skilled in the art to perform the invention without undue experimentation.
While case law such as Lallubhai Chakubhai Jariwala v. Chimanlal Chunilal & Co. is often cited in discussions of patent sufficiency, the broader principle is that a non-enabling disclosure is unlikely to carry strong anticipatory effect in practice.[8]
-
Public Accessibility
The disclosure must be available to the public in a manner that allows retrieval through reasonable diligence.
In In re Hall (Fed. Cir.), a catalogued doctoral thesis was held to constitute prior art due to its accessibility.[9] This principle is widely cited as a comparative illustration of how “public availability” is assessed.
-
Verifiable Date
The disclosure must have a reliably established date of publication.
Accepted mechanisms include indexed technical journals, recognised disclosure databases, and archived conference proceedings. Internal documents without independent timestamping or indexing are generally less reliable in evidentiary contexts.
Risks and Limitations
Defensive publication involves clear trade-offs.
Once disclosed, an invention generally loses patentability in most jurisdictions, subject to limited grace periods in certain legal systems.
A further risk is under-disclosure. Insufficient technical detail may fail to anticipate later claims drafted with greater specificity.
A third risk is inadvertent disclosure of information that may otherwise have been better protected as trade secrets. Accordingly, defensive publication should be governed by structured internal review and clearance processes.
Position Within the IP Framework
Defensive publication operates alongside, not in substitution for, other intellectual property tools.
Patents provide time-limited exclusivity for commercially central inventions. Trade secrets protect information that can be reliably kept confidential. Defensive publication prevents future exclusivity over disclosed subject matter by contributing to the prior art base. Open-source and standards frameworks achieve adoption through contractual and governance mechanisms rather than exclusion.
A mature intellectual property strategy deploys each mechanism based on commercial objective, enforceability, and risk profile.
Conclusion
Intellectual property strategy is not defined by the number of patents held, but by how effectively protection mechanisms align with commercial objectives.
Some inventions justify patent protection. Some justify trade secret protection. Others justify neither but still require structured handling to prevent unintended future exclusion.
In increasingly competitive innovation environments, defensive publication represents a disciplined method of preserving freedom to operate while avoiding unnecessary patent expenditure on marginal subject matter.
Often, the most important strategic decision is not what to protect, but what to ensure cannot later be exclusively appropriated by others.
[1] Patents Act, 1970, s 2(1)(j)
[2] Patents Act, 1970, s 13
[3] Patents Act, 1970, s 25(1)(b) and 25(2)(b)
[4] Patents Act, 1970, s 64(1)(e)
[5] Patents Act, 1970, s 29
[6] Bishwanath Prasad Radhey Shyam v. Hindustan Metal Industries Ltd., AIR 1982 SC 1444.
[7] Monsanto Co. v. Coromandel Indag Products (P) Ltd., AIR 1986 SC 712.
[8] Lallubhai Chakubhai Jariwala v. Chimanlal Chunilal & Co., AIR 1934 Bom 564.
[9] In re Hall, 781 F.2d 897 (Fed. Cir. 1986).